Caris Life Sciences Inc
NASDAQ:CAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
Critical Elements Lithium Corp
F:F12
|
CA |
|
C
|
Construction JSC No 9
VN:VC9
|
VN |
|
S
|
Strauss Group Ltd
TASE:STRS
|
IL |
|
Fuji Electric Co Ltd
TSE:6504
|
JP |
|
H
|
Hasbro Inc
F:HAS
|
US |
|
Palantir Technologies Inc
BMV:PLTR
|
US |
|
S
|
SM Life Design Group Co Ltd
KOSDAQ:063440
|
KR |
|
Corvex, Inc
NASDAQ:MOVE
|
US |
|
P
|
PostNL NV
XMUN:TNTC
|
NL |
|
UBM Development AG
F:2U2
|
AT |
|
Greif Inc
F:GB6B
|
US |
|
P
|
Philip Morris International Inc
F:4I1
|
US |
|
M
|
Medallion Financial Corp
F:MD5
|
US |
|
U
|
UTI Inc
KOSDAQ:179900
|
KR |
|
B
|
Boston Scientific Corp
SWB:BSX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAI's stock price target?
Price Target
27.54
USD
According to Wall Street analysts, the average 1-year price target for CAI is 27.54 USD with a low forecast of 22.22 USD and a high forecast of 34.65 USD.
What is the Revenue forecast for Caris Life Sciences Inc?
Projected CAGR
15%
Over the last 1 year, the compound annual growth rate for Revenue has been 97%. The projected CAGR for the next 8 years is 15%.
What is the Gross Profit forecast for Caris Life Sciences Inc?
Projected CAGR
16%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 200%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for Caris Life Sciences Inc?
Projected CAGR
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.